When a founder or a family sells a business to a private equity buyer, the price is rarely paid entirely in cash at closing. Part of it is often “rolled” into equity in the buyer’s new holding company. Part may come as a promissory note from the buyer. Part may depend on how the business performs after closing, through an earnout.
Each of those pieces is, or may be, a security. The purchase agreement gets most of the lawyers’ attention in a sale, and these instruments often get much less. That is a problem for sellers, because once the deal closes they are no longer owners in control. They are minority investors in a private company run by someone else, holding paper whose value depends on rights they may never have negotiated.
What you are actually holding
Rollover equity. Equity in a limited liability company or limited partnership is almost always a security. Under the Supreme Court’s Howey test, an investment of money in a common enterprise, with an expectation of profits from the efforts of others, is an investment contract. Calling the arrangement a “rollover” does not change that analysis.
Seller notes. Under Reves v. Ernst & Young, every promissory note is presumed to be a security unless it strongly resembles a recognized category of ordinary commercial debt. A seller note may or may not overcome that presumption depending on its purpose, its terms, and how it can be transferred. It is too often treated purely as a loan without anyone asking.
Earnouts. Contingent payments tied to future performance can, depending on how they are structured, also be securities.
Why this matters in practice: the buyer issuing these instruments needs a valid exemption from registration, usually the private placement exemption, and it should be identified and documented when the instruments are issued, not reconstructed after a dispute. The antifraud rules also apply. What the seller was told about the buyer’s plans, capital structure, and the new company’s prospects is part of the record if things go badly.
The rights sellers forget to negotiate
Rollover equity is the most under-negotiated security in a typical private equity sale. Four categories of rights deserve attention before signing.
- Information rights. A minority holder without a contractual right to financial information has no independent way to judge the value or condition of the investment. A reasonable baseline is audited annual financial statements, quarterly management accounts, and notice of material transactions.
- Protection against dilution. Absent express terms, rollover holders can be diluted substantially by later financings or by issuances under management incentive plans. Preemptive rights, which let a holder buy into new issuances to keep its percentage, are routinely left out of rollover term sheets and LLC agreements.
- Transfer and liquidity. Rollover equity is illiquid by design. Sellers should understand the expected exit path and timeline before accepting it. Tag-along rights let a minority holder sell alongside the sponsor on the same terms; drag-along rights let the sponsor force a sale. Both should be negotiated, not assumed. A put right with a defined pricing formula is the strongest protection a seller can obtain and is worth asking for.
- Governance. A board observer can see; a director can vote. Approval rights over major decisions, such as taking on significant new debt, making acquisitions, or changing the nature of the business, protect sellers whose continued involvement was part of the deal.
Tax is part of the same conversation
A rollover is usually structured so that tax on the rolled portion is deferred, under Section 721 of the Internal Revenue Code for contributions to a partnership or Section 351 for a corporation. The conditions must be met precisely at closing. Cash or other property received alongside the rollover is generally taxable when received, and the partnership disguised sale rules can recharacterize what was meant to be a tax-free contribution as a taxable sale. These are not afterthoughts for the tax advisor once the securities terms are settled; the same documents decide both.
Earnouts: plan for the payout you will actually get
Earnouts are common and frequently disappointing. According to SRS Acquiom, earnouts appeared in 24 percent of private-target deals outside life sciences in 2025. Across the deals with earnouts in its data, sellers received some payment in about 59 percent of them, but only about 21 percent of the aggregate maximum earnout value has been paid.
Earnouts measured by EBITDA are especially exposed to decisions the buyer controls after closing: accounting elections, overhead allocations, and intercompany charges. Before signing, sellers should negotiate accounting rules specific to the earnout, acceleration if the business is sold again, and a binding mechanism for resolving disputes. Earnout payments may also arrive years after closing, with tax consequences that depend on how the payments are characterized. The seller’s advisers should still be in place when they do.
Insurance does not cover what many sellers think it covers
- Representations and warranties insurance typically excludes known breaches, matters disclosed in the schedules, purchase price adjustments, and forward-looking statements. Many sellers assume it protects them from securities claims based on what they said before closing. Often it does not.
- Directors and officers coverage for the selling company’s leadership generally ends at closing unless a tail policy is negotiated. Six years is a common term, and it is frequently shortened or omitted to save cost. Claims about pre-closing conduct can surface years later.
- Indemnification provisions in the company’s governing documents should expressly survive the transaction for a defined period and be backed by available funds.
After closing
The closing table is not the end of a seller’s securities law exposure. Securities claims carry limitation periods ranging from one to five years depending on the claim, and former owners who gave representations can face personal exposure if those statements later prove inaccurate. Sellers who receive stock in a public buyer face resale restrictions and lock-ups; sellers rolling into a private holding company face transfer restrictions that may last until the sponsor exits.
Too many sellers dissolve their advisory relationships at closing and are unrepresented when something comes up. A better approach is to keep a coordinated team in place, including securities counsel, a tax advisor, and a wealth manager, and to prepare a post-closing calendar before closing. Every seller should be able to answer three questions on the day the deal closes:
- What exactly do I hold?
- When can I sell or transfer it?
- Who is responsible for telling me when something changes?
This article draws on Jason T. Barnes’s February 2026 program for the Dallas Bar Association Securities Section, Securities Compliance in M&A: A Deal Lawyer’s Playbook. The slides and a two-page quick reference are available on the Speaking & CLE page. Tax matters described here are general; specific tax advice should come from a qualified tax advisor.
Sources
- SEC v. W.J. Howey Co., 328 U.S. 293 (1946); Reves v. Ernst & Young, 494 U.S. 56 (1990).
- SRS Acquiom, M&A earnout and milestone trends and 2026 M&A Deal Terms Study.
- Internal Revenue Code §§351, 707 and 721.
This article is general information, not legal advice, and does not create an attorney-client relationship.